Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known which regimen of chemotherapy is more effective
for breast cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of two different regimens of
combination chemotherapy in treating women who have stage II or stage IIIA breast cancer that
has spread to the lymph nodes.
Phase:
Phase 3
Details
Lead Sponsor:
Eastern Cooperative Oncology Group
Collaborators:
Cancer and Leukemia Group B National Cancer Institute (NCI) North Central Cancer Treatment Group Southwest Oncology Group